Presentations for which the CANM has received permission to post on the Website from speakers; information accurate at date of presentation.
Jean-Mathieu Beauregard & David
Laidley
Fellowships and Future Needs for the Next 5-10 Years for Nuclear Medicine
Jean-Mathieu Beauregard
David Laidley
Session 1A – Theranostics: NET-Overview and Nuclear Diagnosis
NET 101, Current Tx and Challenges
SESSION 1B – Theranostics: NET PRRT Trial Results & Test your NET
PRRT in London, ON
Atelier formatif sur la sélection d’une hotte
Présentation de cas clinique
Xavier Deschamps et Gilles-Philippe
Harvey
Collaboration entre la pharmacie et la médecine nucléaire pour la formation des technologues
en champs stérile sous la hotte
Xavier Deschamps
Gilles-Philippe Harvey
Frédéric Arsenault
La thérapie personnalisée au Lu177
SPECT SUV
PET SUV & The Future of Digital PET
Expérience en Australie: PSMA-Ga68 et PSMA-Lu177
Blindage d’un nouveau service de médecine nucléaire: Conception, radioprotection et coûts
AOFNMB - Jun Hatazawa
SNMMI - Women in Nuclear Medicine
ASNC - ASNC: Your Nuclear Cardiology Companion
Radionuclide therapy and Skin Cancer: Focus on Re-188 Shannon Brown
Tassia Godoy
SESSION 5 – Theranostics: Prostate Cancer
Prostate Cancer 101: mCRPC, Treatment & Challenges
Canadian PSMA PET Experience
Finnish PSMA PET and RLT Experience
Canadian PSMA RLT Trial
Atelier sur le CT en médecine nucléaire et au TEP
Round-table on the Future of NM Practice in Canada, with Respect to Radionuclide Therapy
Session 8 – Are You Ready For the Trends in Nuclear Medicine in 2019-2020?
Does Dynamic PET Imaging Have a Future in Clinical Oncologic Practice?
Nuclear Diagnosis of Infiltrative Cardiac Disease
Nuclear Medicine and Social Media: A New Paradigm
Présentation sur le Datscan
Dosimétrie pour les patients traités en médecine nucléaire
Session 10 - DATSCAN
All You Need to Know About Datscan